Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OcciGuide is a medical device company that develops precision guidance tools for interventional pain management, specifically targeting chronic headache disorders. The company's flagship product, the OcciGuide, is a disposable, single-use device designed to standardize the administration of Greater Occipital Nerve (GON) blocks. By utilizing anatomical landmarks to ensure consistent needle placement, the device aims to improve the accuracy and efficacy of nerve blocks for patients suffering from chronic migraines, occipital neuralgia, and cluster headaches. OcciGuide's technology is intended to simplify the procedure for a wide range of healthcare providers, including neurologists and primary care physicians. The company focuses on enhancing patient outcomes through improved procedural reliability in the treatment of debilitating head pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OcciGuide.